Standout Papers

The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases 2022 2026 2023 2024288
  1. The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases (2022)
    Hallie Blevins, Yiming Xu et al. Frontiers in Aging Neuroscience

Immediate Impact

59 standout
Sub-graph 1 of 22

Citing Papers

Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
2025 Standout
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
5 intermediate papers

Works of Hallie Blevins being referenced

CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing
2023
A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer’s Disease Transgenic Mice
2021
and 1 more

Author Peers

Author Last Decade Papers Cites
Hallie Blevins 337 48 123 73 9 490
Qing Li 332 35 96 49 15 489
Yingxin Sun 369 66 131 28 10 494
Xuan Xu 260 44 61 40 19 554
Víctor Farré‐Alins 230 43 61 25 12 470
Damaris B. Skouras 388 82 124 90 6 521
Beatriz Castejón‐Vega 313 39 115 33 16 546
Huajun Zhang 314 15 50 63 15 501
Xuan Li 348 83 200 18 8 520
Anna Hammer 182 26 80 20 11 421
Zhanfei Li 323 20 148 21 16 480

All Works

Loading papers...

Rankless by CCL
2026